InvestorsHub Logo
Followers 3
Posts 1973
Boards Moderated 1
Alias Born 11/02/2016

Re: None

Saturday, 04/23/2022 7:27:17 AM

Saturday, April 23, 2022 7:27:17 AM

Post# of 16427
Why BB so quiet now ?




It appears the other board not too happy with the way things are.....just repeating this again so everyone can see how awesome he used to tell you the tech was....So well position to dominate ? He used to put out some interesting stuff didn't he ? Was he really anywhere near WELL positioned to dominate ?


""Back in 2012.....



"
"Global in vitro diagnostics is currently estimated to have an annual value of $44 billion USD. NanoLogix’s management is focused on positioning our BNP and BNF technology to enter and capture a significant portion of that market. We believe that businesses, and indeed whole industries, that need or supply diagnostics will choose our faster, simpler and cheaper technology over expensive, highly complex equipment that cannot differentiate between live active-threat and dead bacteria.



2019.....



Global Diagnostics Market

• In the US alone, the market in diagnostics is expected to grow to 20 billion by the year 2022.

• Globally, this is anticipated to reach 31 billion by 2026.

• Given the unique features of the N-Assay (its ability to identify a pathogen and simultaneously determine the correct antibiotic to guide treatment), its ease of use (may be developed as a point-of- care test, which may be used at the patient’s bedside, in the clinic, or even at home), its low cost to manufacture, its high rate of accuracy (see publications listed on next slide), and its ability to differentiate between viable and non-viable pathogens, this assay is well positioned to dominate the market.